Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.52 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | THPO | P40225 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20502169 | 1.00 | CYP3A4 (0.52) | CYP3A4SLC7A5DPP4HRH4HRH3 | |
| Hydrochloric Acid SCHEMBL20658884 | 0.99 | CYP3A4 (0.51) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| SCHEMBL17223938 | 0.83 | CYP3A4 (0.52) | CYP3A4SLC7A5DPP4HRH4HRH3 | |
| SCHEMBL388562 | 0.77 | CYP3A4 (0.73) | CYP3A4SLC7A5HRH4HRH3MEN1 | |
| SCHEMBL15911724 | 0.77 | CYP3A4 (0.63) | CYP3A4SLC7A5HRH4HRH3MEN1 | |
| SCHEMBL163444 | 0.76 | CYP3A4 (0.71) | CYP3A4SLC7A5HRH4HRH3MEN1 | |
| SCHEMBL1537285 | 0.76 | CYP3A4 (0.71) | CYP3A4SLC7A5HRH4HRH3MEN1 | |
| Hydrochloric Acid SCHEMBL28268597 | 0.76 | CYP3A4 (0.61) | CYP3A4SLC7A5HRH4HRH3MEN1 | |
| Hydrochloric Acid SCHEMBL28331180 | 0.75 | CYP3A4 (0.69) | CYP3A4SLC7A5HRH4HRH3MEN1 | |
| SCHEMBL3435176 | 0.75 | CYP3A4 (0.69) | CYP3A4SLC7A5HRH4HRH3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023126947-A1 | DETERMINATION OF THE TRAPPED VOLUME OF A LIPOSOME | MOEBIUS MEDICAL LTD. (IL) | 2023-07-06 | — | — | WO | disclosed |
| CN-114727960-A | Liposomal cannabinoids and uses thereof | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 2022-07-08 | — | — | CN | disclosed |
| US-20140154308-A1 | Microparticle Formulations for Delivery to the Upper and Central Respiratory Tract and Methods of Manufacture | ANSUN BIOPHARMA, INC. | 2014-06-05 | — | — | US | disclosed |
| EP-2658572-A1 | FLUOROCARBON-LINKED PEPTIDE FORMULATION | Immune Targeting Systems (ITS) Limited (GB) | 2013-11-06 | — | — | EP | disclosed |
| WO-2012090002-A1 | FLUOROCARBON-LINKED PEPTIDE FORMULATION | IMMUNE TARGETING SYSTEMS (ITS) LTD (GB) | 2012-07-05 | — | — | WO | disclosed |
| US-6013773-A | STABLE SOLUTION CONTAINING SOMATOTROPIN, NICOTINAMIDE AND SODIUM ACETYLTRYPTOPHANE ; FOR INCREASED SOLUBILITY OF SOMATOTROPIN | MITSUI CHEMICALS, INC. (JP) | 2000-01-11 | — | — | US | disclosed |